JP2023521887A5 - - Google Patents
Info
- Publication number
- JP2023521887A5 JP2023521887A5 JP2022562668A JP2022562668A JP2023521887A5 JP 2023521887 A5 JP2023521887 A5 JP 2023521887A5 JP 2022562668 A JP2022562668 A JP 2022562668A JP 2022562668 A JP2022562668 A JP 2022562668A JP 2023521887 A5 JP2023521887 A5 JP 2023521887A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- sustained
- pirfenidone
- composition according
- release
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063010009P | 2020-04-14 | 2020-04-14 | |
| US63/010,009 | 2020-04-14 | ||
| PCT/US2021/027335 WO2021211745A1 (en) | 2020-04-14 | 2021-04-14 | Pirfenidone for coronavirus treatment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023521887A JP2023521887A (ja) | 2023-05-25 |
| JP2023521887A5 true JP2023521887A5 (cg-RX-API-DMAC7.html) | 2024-04-25 |
Family
ID=78084909
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022562668A Pending JP2023521887A (ja) | 2020-04-14 | 2021-04-14 | コロナウイルス治療のためのピルフェニドン |
Country Status (14)
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2007009796A (es) | 2007-08-14 | 2009-02-25 | Cell Therapy And Technology S | Gel conteniendo pirfenidona. |
| MX2011007675A (es) | 2011-07-19 | 2012-07-11 | Cell Therapy And Technology S A De C V | Procedimiento para la fabricacion de una composicion farmaceutica en forma de tabletas de liberacion prolongada conteniendo pirfenidona y su aplicacion en la regresion de la insuficiencia renal cronica, contractura capsular mamaria y fibrosis hepatica humanas. |
| MX356551B (es) | 2012-08-23 | 2018-06-04 | Grupo Medifarma S A De C V Star | Composición antiséptica, antiseborreica y exfoliante para eliminar o prevenir el acné. |
| MX368750B (es) | 2018-08-31 | 2019-10-15 | Cell Therapy And Tech S A De C V | Composiciones farmaceuticas semisolidas de base oleosa conteniendo pirfenidona para su aplicacion en la reparacion tisular. |
| CN114796122B (zh) * | 2022-03-30 | 2023-03-24 | 山东大学 | 一种聚多巴胺载吡菲尼酮纳米粒及其制备方法和应用 |
| JP7845721B2 (ja) * | 2022-04-29 | 2026-04-14 | オーバーシーズ ファーマシューティカルズ リミテッド | ピルフェニドンの経口用持続放出性固形製剤 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU709178B2 (en) * | 1995-09-19 | 1999-08-26 | Intermune, Inc. | Inhibition of tumor necrosis factor alpha |
| US20020028784A1 (en) * | 2000-03-10 | 2002-03-07 | Nest Gary Van | Methods of preventing and treating viral infections using immunomodulatory polynucleotide sequences |
| US20030103941A1 (en) * | 2001-10-09 | 2003-06-05 | Crombleholme Timothy M. | Materials and methods for preventing or reducing scar formation |
| WO2005013917A2 (en) * | 2003-02-28 | 2005-02-17 | Intermune, Inc. | Combination therapy for treating alphavirus infection and liver fibrosis |
| WO2005000227A2 (en) * | 2003-06-06 | 2005-01-06 | Intermune, Inc. | Methods of treating tnf-mediated disorders |
| WO2005040758A2 (en) * | 2003-10-24 | 2005-05-06 | Intermune, Inc. | Use of pirfenidone in therapeutic regimens |
| AP2007004244A0 (en) * | 2005-05-10 | 2007-12-31 | Intermune Inc | Method of modulating stress-activated protein kinase system |
| NZ591443A (en) * | 2005-09-22 | 2013-04-26 | Intermune Inc | Granule formation of pirfenidone and pharmaceutically acceptable excipients |
| CN101088557A (zh) * | 2006-06-12 | 2007-12-19 | 天津市扶素生物技术有限公司 | 用于预防或治疗hiv感染的药用组合物及其应用 |
| US20080287508A1 (en) * | 2007-05-18 | 2008-11-20 | Intermune, Inc. | Altering pharmacokinetics of pirfenidone therapy |
| WO2010132864A1 (en) * | 2009-05-15 | 2010-11-18 | Intermune, Inc. | Methods of treating hiv patients with anti-fibrotics |
| CN101972236A (zh) * | 2010-10-13 | 2011-02-16 | 北京诚创康韵医药科技有限公司 | 一种含吡非尼酮的缓释制剂 |
| HUE058753T2 (hu) * | 2011-01-31 | 2022-09-28 | Avalyn Pharma Inc | Aeroszol formájú pirfenidon- és piridon-analóg vegyületek és alkalmazásaik |
| MX2011007675A (es) * | 2011-07-19 | 2012-07-11 | Cell Therapy And Technology S A De C V | Procedimiento para la fabricacion de una composicion farmaceutica en forma de tabletas de liberacion prolongada conteniendo pirfenidona y su aplicacion en la regresion de la insuficiencia renal cronica, contractura capsular mamaria y fibrosis hepatica humanas. |
| WO2013181691A1 (en) * | 2012-06-04 | 2013-12-12 | The Macfarlane Burnet Institute For Medical Research And Public Health Ltd | A method of treatment and compositions useful therefor, screening and prognostic agents and uses therefor |
| JP7066321B2 (ja) * | 2014-01-10 | 2022-05-13 | アヴァリン ファーマ インク. | エアロゾルのピルフェニドン及びピリドンのアナログの化合物、及び、その使用 |
-
2021
- 2021-04-14 KR KR1020227039706A patent/KR20230038644A/ko active Pending
- 2021-04-14 WO PCT/US2021/027335 patent/WO2021211745A1/en not_active Ceased
- 2021-04-14 AU AU2021254765A patent/AU2021254765A1/en not_active Abandoned
- 2021-04-14 US US17/918,791 patent/US20230117397A1/en not_active Abandoned
- 2021-04-14 MX MX2022012986A patent/MX2022012986A/es unknown
- 2021-04-14 BR BR112022020821A patent/BR112022020821A2/pt not_active Application Discontinuation
- 2021-04-14 EP EP21788910.4A patent/EP4135671A4/en not_active Withdrawn
- 2021-04-14 CA CA3175526A patent/CA3175526A1/en active Pending
- 2021-04-14 CN CN202180042472.1A patent/CN115916162A/zh active Pending
- 2021-04-14 IL IL297296A patent/IL297296A/en unknown
- 2021-04-14 JP JP2022562668A patent/JP2023521887A/ja active Pending
-
2022
- 2022-10-14 CL CL2022002843A patent/CL2022002843A1/es unknown
- 2022-11-11 CO CONC2022/0016155A patent/CO2022016155A2/es unknown
- 2022-11-14 EC ECSENADI202287664A patent/ECSP22087664A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4041212B1 (en) | Mek inhibitors for the treatment of hantavirus infections | |
| JP2007506775A5 (cg-RX-API-DMAC7.html) | ||
| CN115916162A (zh) | 用于冠状病毒治疗的吡非尼酮 | |
| JP4627356B2 (ja) | ウイルス性心筋炎の予防または治療薬剤 | |
| JPWO2023054732A5 (cg-RX-API-DMAC7.html) | ||
| JP2025508656A5 (cg-RX-API-DMAC7.html) | ||
| JP2026041886A5 (cg-RX-API-DMAC7.html) | ||
| FI3706724T3 (fi) | Suun kautta otettavia rifamysiini sv -koostumuksia | |
| WO2010149641A2 (en) | Pharmaceutical agent | |
| CA3190278A1 (en) | Antiviral use of liraglutide and gefitinib | |
| JP2022540348A5 (cg-RX-API-DMAC7.html) | ||
| JP2023510965A5 (cg-RX-API-DMAC7.html) | ||
| JP2024084670A5 (cg-RX-API-DMAC7.html) | ||
| CN115778944A (zh) | 蛇床子素在制备改善或治疗认知功能障碍的药物中的用途 | |
| CN113440614A (zh) | 一种用于治疗类风湿性关节炎的组合物及其应用 | |
| JP2025522146A5 (cg-RX-API-DMAC7.html) | ||
| CN107308121A (zh) | 肝脏再生的治疗剂 | |
| CA3152450C (en) | Mek inhibitors for the treatment of hantavirus infections | |
| US20240382510A1 (en) | New combination drug for treating coronavirus infections, pharmaceutical composition and use thereof | |
| US20100022576A1 (en) | Stable and bioavailable formulations and a novel form of desloratadine | |
| RU2498803C1 (ru) | Противотуберкулезное лекарственное средство | |
| JP4593953B2 (ja) | ライノウイルス感染症の予防薬 | |
| CN119055633A (zh) | 一类甲基麦冬黄酮a类衍生物在制备防治肝脏疾病药物中的应用 | |
| WO2025190943A1 (en) | Pharmaceutical composition comprising a fixed dose combination of ivermectin and albendazole | |
| CN118370758A (zh) | 托法替尼在制备治疗流感病毒感染的药物中的应用 |